ATXS
Price:
$6.71
Market Cap:
$378.67M
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
Industry
Biotechnology
IPO Date
2015-06-25
Stock Exchange
NASDAQ
Ticker
ATXS
According to Astria Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.31%. This represents a change of 293.95% compared to the average of -8.46% of the last 4 quarters.
The mean historical ROE of Astria Therapeutics, Inc. over the last ten years is -76.69%. The current -33.31% ROE has changed -56.56% with respect to the historical average. Over the past ten years (40 quarters), ATXS's ROE was at its highest in in the March 2021 quarter at 168.16%. The ROE was at its lowest in in the March 2018 quarter at -59.18%.
Average
-76.69%
Median
-69.05%
Minimum
-232.06%
Maximum
-23.43%
Discovering the peaks and valleys of Astria Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.85%
Maximum Annual ROE = -23.43%
Minimum Annual Increase = -315.72%
Minimum Annual ROE = -232.06%
Year | ROE | Change |
---|---|---|
2024 | -29.52% | -1.53% |
2023 | -29.98% | 27.96% |
2022 | -23.43% | -5.02% |
2021 | -24.67% | -72.93% |
2020 | -91.14% | 24.05% |
2019 | -73.47% | -0.77% |
2018 | -74.04% | -68.10% |
2017 | -232.06% | 87.18% |
2016 | -123.98% | 91.85% |
2015 | -64.62% | -315.72% |
The current ROE of Astria Therapeutics, Inc. (ATXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.65%
5-year avg
-39.75%
10-year avg
-76.69%
Astria Therapeutics, Inc.’s ROE is less than Jade Biosciences, Inc. (200.78%), greater than Anebulo Pharmaceuticals, Inc. (-90.11%), greater than Mineralys Therapeutics, Inc. (-71.15%), greater than Enliven Therapeutics, Inc. (-31.84%), greater than Adagene Inc. (-76.84%), greater than Larimar Therapeutics, Inc. (-52.48%), greater than Biomea Fusion, Inc. (-152.73%), greater than Annexon, Inc. (-54.45%),
Company | ROE | Market cap |
---|---|---|
200.78% | $340.25M | |
-90.11% | $71.08M | |
-71.15% | $937.22M | |
-31.84% | $1.29B | |
-76.84% | $73.87M | |
-52.48% | $218.66M | |
-152.73% | $109.77M | |
-54.45% | $256.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Astria Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Astria Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Astria Therapeutics, Inc.'s ROE?
How is the ROE calculated for Astria Therapeutics, Inc. (ATXS)?
What is the highest ROE for Astria Therapeutics, Inc. (ATXS)?
What is the 3-year average ROE for Astria Therapeutics, Inc. (ATXS)?
What is the 5-year average ROE for Astria Therapeutics, Inc. (ATXS)?
How does the current ROE for Astria Therapeutics, Inc. (ATXS) compare to its historical average?